Study of the Bria-IMT Regimen and CPI vs Physicians’ Choice in Advanced Metastatic Breast Cancer (BRIA-ABC)
NCT ID : 06072612
Phase : 3
Location : Saint John's Cancer Institute
|
Breast Surgery and Oncology
|
Parvin Peddi, M.D.
|
A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer
NCT ID : 05483868
Phase : 1
Location : Saint John's Cancer Institute
|
Urology and Urologic Oncology
|
Jennifer Linehan, M.D.
|
A Study of Tobemstomig + Nab-Paclitaxel Compared With Pembrolizumab + Nab-Paclitaxel in Participants With Previously Untreated, PD-L1-Positive, Locally-Advanced Unresectable or Metastatic Triple-Negative Breast Cancer
NCT ID : 05852691
Phase : 2
Location : Saint John's Cancer Institute
|
Breast Surgery and Oncology
|
Reva Basho, M.D.
|
Perioperative Pain Management Strategies in Oncoplastic Breast Surgery
NCT ID : N/A
Phase : N/A
Location : Saint John's Cancer Institute
|
Breast Surgery and Oncology
|
Janie Grumley, M.D.
|
Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer (Solar-Recur)
NCT ID : 06235151
Phase : 3
Location : Saint John's Cancer Institute
|
Urology and Urologic Oncology
|
Przemyslaw Twardowski, M.D.
|
Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer (Solar-Recur)
NCT ID : 06235099
Phase : 3
Location : Saint John's Cancer Institute
|
Urology and Urologic Oncology
|
Przemyslaw Twardowski, M.D.
|
A Randomized Controlled Phase 2 Study of the Ketogenic Diet Versus Standard Dietary Guidance for Patients With Newly Diagnosed Glioblastoma in Combination With Standard-of-care Treatment
NCT ID : 05708352
Protocol Number : IIT2022-06-HU-DIET2TREAT
Phase : 2
Location : Santa Monica, CA
|
Brain Tumors & Neuroscience
|
Akanksha Sharma, M.D.
|
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
NCT ID : 05894239
Protocol Number : WO44263
Phase : 3
Location : Burbank, California
|
Breast Surgery and Oncology
|
Reva Basho, M.D.
|
Study of Chemotherapy Plus Ipatasertib for People With Solid Tumors With AKT Mutations, A ComboMATCH Treatment Trial
NCT ID : 05554380
Protocol Number : EAY191-S3
Phase : 2
Location : Santa Monica, CA
|
Multiple Tumors
|
Reva Basho, M.D.
|
Testing the Use of Fulvestrant and Binimetinib Targeted Treatment for NF1 Mutation in Hormone Receptor-Positive Metastatic Breast Cancer (A ComboMATCH Treatment Trial)
NCT ID : 05554354
Phase : 2
Location : Santa Monica, CA
|
Breast Surgery and Oncology
|
Reva Basho, M.D.
|
Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial
NCT ID : 05710328
Protocol Number : EA1211
Phase : 2
Location : Santa Monica, Ca
|
Breast Surgery and Oncology
|
Parvin Peddi, M.D.
|
A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery
NCT ID : 05608291
Protocol Number : R3767-ONC-2055
Phase : 3
Location : Saint John's Cancer Institute
|
Melanoma, Skin and Soft Tissue Tumors
|
Kim Margolin, M.D.
|
A Beta-only IL-2 Immunotherapy Study (ABILITY-1)
NCT ID : 05086692
Protocol Number : MDNA 11-01
Phase : 1/2
Location : Saint John's Cancer Institute
|
All Solid Tumors
|
Przemyslaw Twardowski, M.D.
|
A Study of ARV-766 Given by Mouth in Men With Metastatic Castration-resistant Prostate Cancer Who Have Progressed on Prior Approved Systemic Therapies
NCT ID : 05067140
Protocol Number : ARV-766mCRPC-101
Phase : 1/2
Location : Saint John's Cancer Institute
|
Urology and Urologic Oncology
|
Przemyslaw Twardowski, M.D.
|
Study of REGN5678 (Anti-PSMAxCD28) With Cemiplimab (Anti-PD-1) in Patients With Metastatic Castration-resistant Prostate Cancer
NCT ID : 03972657
Protocol Number : R5678-ONC-1879
Phase : 1/2
Location : Saint John's Cancer Institute
|
Urology and Urologic Oncology
|
Przemyslaw Twardowski, M.D.
|
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
NCT ID : 05812807
Protocol Number : A012103
Phase : 3
Location : Saint John's Cancer Institute
|
Breast Surgery and Oncology
|
Parvin Peddi, M.D.
|
A Study to Test Different Doses of BI 1831169 Alone and in Combination With Ezabenlimab in People With Different Types of Advanced Cancer (Solid Tumors)
NCT ID : 05155332
Protocol Number : 1456-0001
Phase : 1
Location : Saint John's Cancer Institute
|
All Solid Tumors
|
Naveed Wagle, M.D.
|
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study) (ACTION)
NCT ID : 05580562
Protocol Number : ONC201-108
Phase : 3
Location : Saint John's Cancer Institute
|
Brain Tumors & Neuroscience
|
Akanksha Sharma, M.D.
|
Biomarker Low Risk Node Positive Breast Cancer: TAILOR RT.
NCT ID : 03488693
Protocol Number : CCTGMA.39
Phase : 3
Location : Santa Monica, CA
|
Breast Surgery and Oncology
|
Janie Grumley, M.D.
|
Monitoring Symptoms to Help Young Women Take Hormone Therapy for Stage I-III Breast Cancer, ASPEN Study
NCT ID : 05568472
Protocol Number : SWOG-S2010
Phase : 3
Location : Saint John's Cancer Institute
|
Breast Surgery and Oncology
|
Janie Grumley, M.D.
|
White Button Mushroom Supplement for Biochemically Recurrent Prostate Cancer Following Local Therapy and in Therapy Naïve Patients
NCT ID : 04519879
Protocol Number : White Button Mushroom
Phase : 2
Location : Santa Monica, CA
|
Urology and Urologic Oncology
|
Przemyslaw Twardowski, M.D.
|
Intermediate-size Expanded Access to ONC201 for Patients with H3 K27M-mutant and/or Midline Gliomas
NCT ID : 04617002
Protocol Number : ONC028
Phase : N/A
Location : Santa Monica, CA
|
Brain Tumors & Neuroscience
|
Akanksha Sharma, M.D.
|
Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients With Recurrent High-Grade Glioma
NCT ID : 05561374
Protocol Number : OKN-007-OL
Phase : 1
Location : Saint John's Cancer Institute
|
Brain Tumors & Neuroscience
|
Naveed Wagle, M.D.
|
DecisionDx-Melanoma Impact on Sentinel Lymph Node Biopsy Decisions and Clinical Outcomes (DECIDE)
NCT ID : N/A
Protocol Number : CBI_2019_SLNBprosp_001
Phase : N/A
Location : Santa Monica, CA
|
Melanoma, Skin and Soft Tissue Tumors
|
Richard Essner, M.D.
|